Clinical Trial Update: Sarcopenia and CRP-TyG Index (CTI) as Predictors of Immunotherapy Response in Metastatic Non-Small Cell Lung Cancer

View source ↗

Summary

This completed clinical trial investigated whether sarcopenia and the CRP-TyG (CTI) index can predict response to immunotherapy in metastatic non-small cell lun…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Ankara Etlik City Hospital | Conditions: Metastatic Non-small Cell Lung Cancer, Neoplasm | Status: COMPLETED